Table 1.
NPC | Schizophrenia (SZ) | |
---|---|---|
n | 20 | 20 |
Age, mean ± SD | 47.7 ± 9.5 | 45.4 ± 9.3 |
Sex, M/F | 14/6 | 14/6 |
pH, mean ± SD | 6.7 ± 0.2 | 6.5 ± 0.3 |
PMI, hours ± SD | 15.5 ± 5.7 | 14.5 ± 6.1 |
Storage time, months ± SD | 114.1 ± 42.8 | 113.6 ± 48.9 |
Nicotine ATOD, Y/N | 14/4 | |
Antipsychotic ATOD, Y/N | 18/2 | |
Antidepressant ATOD, Y/N | 11/9 | |
Benzodiazepine/VPA ATOD, Y/N | 5/15 | |
Asphyxiation, Y/N | 3/17 | 8/12 |
Hypoxia, Y/N | 4/16 | 4/16 |
Ischemia, Y/N | 0/20 | 5/15 |
AHI, Y/N | 6/14 | 12/8 |
Diagnostic groups showed no significant differences in age (t37 = 0.68, p = 0.50), PMI (t37 = 0.55, p = 0.58), storage time (t37 = 0.14, p = 0.89), pH (t34 = 1.79, p = 0.08), nor in frequency of asphyxiation (X2[1,N = 20] = 3.13, p = 0.08), ischemia (X2[1,N = 20] = 3.66, p = 0.06), hypoxia, or the presence of one or more of these risk variables (AHI; see text) (X2[1,N = 20] = 3.64, p = 0.06). Additional cohort details can be found in Supplementary Table 1
SD standard deviation, PMI postmortem interval, M male, F female, ATOD at time of death, AHI asphyxiation/hypoxia/ischemia (see text)